Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | Senexin B | 0.316227766017 | 0.7736 | -0.00389 |
| HCC1395 | Senexin B | 1.0 | 0.7975 | 0.03592 |
| HCC1395 | Senexin B | 1.0 | 0.6328 | 0.02503 |
| HCC1395 | Senexin B | 1.0 | 0.6801 | 0.00024 |
| HCC1395 | Senexin B | 3.16227766017 | 0.5068 | 0.03466 |
| HCC1395 | Senexin B | 3.16227766017 | 0.5872 | 0.01854 |
| HCC1395 | Senexin B | 3.16227766017 | 0.8514 | -0.00533 |
| HCC1395 | Senexin B | 10.0 | 0.3076 | 0.04815 |
| HCC1395 | Senexin B | 10.0 | 0.3937 | -0.00278 |
| HCC1395 | Senexin B | 10.0 | 0.2209 | 0.01006 |
| HCC1419 | MK 1775 | 0.001 | 0.9738 | -0.00158 |
| HCC1419 | MK 1775 | 0.001 | 1.0261 | -0.00464 |
| HCC1419 | MK 1775 | 0.001 | 0.7906 | -0.00235 |
| HCC1419 | MK 1775 | 0.00316227766017 | 0.8004 | -0.00447 |
| HCC1419 | MK 1775 | 0.00316227766017 | 1.0235 | -0.00492 |
| HCC1419 | MK 1775 | 0.00316227766017 | 0.7906 | -0.00045 |
| HCC1419 | MK 1775 | 0.01 | 0.8452 | -0.00397 |
| HCC1419 | MK 1775 | 0.01 | 0.9290 | 0.00080 |
| HCC1419 | MK 1775 | 0.01 | 1.0532 | -0.00772 |
| HCC1419 | MK 1775 | 0.0316227766017 | 0.6395 | -0.00134 |
| HCC1419 | MK 1775 | 0.0316227766017 | 1.0261 | 0.00050 |
| HCC1419 | MK 1775 | 0.0316227766017 | 0.8463 | 0.00110 |
| HCC1419 | MK 1775 | 0.1 | 0.8430 | 0.00155 |
| HCC1419 | MK 1775 | 0.1 | 0.8886 | 0.02608 |
| HCC1419 | MK 1775 | 0.1 | 0.6813 | 0.00617 |